产品特点
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Amolin 100mg Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100mg atenolol.
Each tablet also contains 61.80mg lactose monohydrate
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
White, round, biconvex scored tablet with inscription on the upper side: “C25”.
The scoreline allows the tablet to be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
-
Management of hypertension
-
Management of angina pectoris
-
Management of cardiac dysrhythmias
-
Myocardial infarction: early intervention in the acute phase.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
The dosage should be individually determined, based mainly on the pulse rate or the therapeutical effectiveness. It is
advisable to start the therapy with the lowest possible dosage in order to be able to identify cardiac decompensation or
bronchial phenomena at an early stage; this is especially important in the elderly. With Amolin a stepwise increase up
to the fully effective dose is possible. Subsequent increases in dose should take place slowly (e.g. once a week) under
control or on the basis of clinical effect.
Adults
HYPERTENSION:
While some patients will respond to a single daily dose of 50 mg, the usual daily dosage is 100 mg as a single dose.
The effect will be fully established after one to two weeks. A further reduction in blood pressure may be achieved by
combining Amolin with other antihypertensive agents, e.g. a diuretic.
ANGINA PECTORIS:
The usual daily dose is 100 mg given once daily or 50 mg twice daily. It is unlikely that additional benefit will be
gained by increasing the dose.
DYSRHYTHMIAS:
Following control of the dysrhythmia with intravenous atenolol, a sui
阅读完整的文件
产品特点 